Pear Therapeutics, Inc.
PEARDelisted May 2, 2023- Industry
- Services-Health Services
- SEC CIK
- 0001835567
Pear Therapeutics, Inc. was delisted on May 2, 2023; its insiders filed their last Form 4 on Apr 12, 2023; 53 institutions reported holding it in 13F filings for Q1 2023, worth $20.7M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Pear Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +25 vs. Q3 2021
- Shares held
- 74.9M
- +74.9M vs. Q3 2021
- Total value
- $464.3M
- +$464.3M vs. Q3 2021
- New holders
- 25
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PEAR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 1 | $0 |
| Q2 2023 | 1 | $0 |
| Q1 2023 | 53 | $20.7M |
| Q4 2022 | 64 | $96.3M |
| Q3 2022 | 60 | $168.1M |
| Q2 2022 | 40 | $118.4M |
| Q1 2022 | 48 | $385.3M |
| Q4 2021 | 25 | $464.3M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Pear Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Temasek Holdings (Private) Ltd | 26,803,573 | $166.2M | 0.60% | +26,803,573 | New |
| 5AM Venture Management, LLC | 18,631,771 | $115.5M | 21.68% | +18,631,771 | New |
| SB Global Advisers Ltd | 12,100,078 | $75.0M | 1.49% | +12,100,078 | New |
| Arboretum Ventures, Inc. | 10,859,050 | $67.3M | 38.79% | +10,859,050 | New |
| TB Alternative Assets Ltd. | 2,071,865 | $12.8M | 3.80% | +2,071,865 | New |
| Palantir Technologies Inc. | 1,000,000 | $6.20M | 2.81% | +1,000,000 | New |
| Perceptive Advisors LLC | 926,232 | $5.74M | 0.09% | +926,232 | New |
| Alpine Global Management, LLC | 625,134 | $3.88M | 0.58% | +625,134 | New |
| Vanguard Group Inc | 622,639 | $3.86M | 0.00% | +622,639 | New |
| Sarissa Capital Management LP | 500,356 | $3.10M | 0.27% | +500,356 | New |
| EDBI Pte Ltd | 426,371 | $2.64M | 1.44% | +426,371 | New |
| Blue Water Life Science Advisors, LLC | 194,686 | $1.21M | 0.37% | +194,686 | New |
| Geode Capital Management, LLC | 58,053 | $359.0K | 0.00% | +58,053 | New |
| Ergoteles LLC | 36,300 | $225.0K | 0.01% | +36,300 | New |
| Penserra Capital Management LLC | 6,052 | $37.0K | 0.00% | +6,052 | New |
| Tower Research Capital LLC (TRC) | 5,257 | $33.0K | 0.00% | +5,257 | New |
| Roble, Belko & Company, Inc | 4,502 | $28.0K | 0.01% | +4,502 | New |
| BerganKDV Wealth Management, LLC | 4,500 | $28.0K | 0.00% | +4,500 | New |
| UBS Group AG | 4,369 | $27.0K | 0.00% | +4,369 | New |
| Washington Trust Advisors, Inc. | 3,000 | $19.0K | 0.00% | +3,000 | New |
| Morgan Stanley | 2,422 | $15.0K | 0.00% | +2,422 | New |
| Advisor Group Holdings, Inc. | 914 | $6.00K | 0.00% | +914 | New |
| Concord Wealth Partners | 1,000 | $6.00K | 0.00% | +1,000 | New |
| Patriot Financial Group Insurance Agency, LLC | 500 | $3.00K | 0.00% | +500 | New |
| DuPont Capital Management Corp | 2 | $0 | 0.00% | +2 | New |